Phenotypic Exploration of Autism Spectrum Disorders Retrospective and Prospective Data
Assistance Publique - Hôpitaux de Paris
1,500 participants
Jul 1, 2021
OBSERVATIONAL
Conditions
Summary
Autism Spectrum Disorders (ASD) are a heterogeneous group of severe developmental abnormalities of the nervous system characterized by deficits in social interaction and verbal and nonverbal communication affecting approximately 1% of the general population. In 5-40% of cases, genetic factors are identified as the cause of these disorders. Despite this unique definition and the advancement of techniques, ASD is still a clinically and genetically heterogeneous condition, as several hundred genes have been identified to date. Primary Objective and Endpoint Primary Objective: Exploration of phenotypic heterogeneity in patients with ASD. Primary endpoint: * Routine Care Clinical Investigation Criteria. * Scores on assessment scales,
Eligibility
Inclusion Criteria1
- child (age <18 years) with Autism Spectrum DisorderAutism Spectrum Disorder
Exclusion Criteria1
- \-
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
No intervention
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04923854